Document is current

Any future updates will be listed below

Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-κB/miR-155/PU.1 pathway

Crossref DOI link: https://doi.org/10.1186/s12885-017-3145-4

Published Online: 2017-02-21

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark